Published in Drug Week, March 31st, 2006
Rotarix will be the first vaccine available to children in Europe for the prevention of gastroenteritis caused by rotavirus. GSK intends to introduce this vaccine throughout Europe now that marketing authorization has been granted.
"We are delighted that our partner GSK has received approval of Rotarix in Europe," said Una S. Ryan, PhD, president and CEO of Avant Immunotherapeutics. "European approval marks a significant milestone for the global...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.